Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) reaches its highest concentration in the blood roughly one to three days after each weekly injection, with peak levels typically around day two. That timing shapes everything from when side effects feel strongest to when appetite suppression is most pronounced. As a prescription-only medicine, Wegovy is only available following a clinical assessment by a prescriber who decides whether it is suitable for you. Understanding the peak helps you make sense of the pattern your body follows each week, and it is the question many people find themselves quietly Googling after their first or second pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picking your injection day is not just an administrative choice. Because Wegovy peaks around 24–72 hours after the dose, the day you choose determines which days of your week carry the highest drug levels. Most people notice that nausea, fatigue or a reduced appetite feels more pronounced in roughly that window after injecting. If you inject on a Monday evening, Tuesday and Wednesday are the days to keep lighter on commitments if you are still settling in. That is the practical implication of the peak.
The question of which day to take Wegovy is worth thinking through before you start rather than after. Some people pick Friday evening deliberately, the peak lands over the weekend when they are not at work and can take it easy. Others choose Sunday so the peak clears before the working week. There is no clinically superior day; the best one is whichever you can stick to consistently. Consistency matters far more than peak timing, because semaglutide depends on a steady weekly rhythm to build and maintain stable levels.
One practical check you can do in under a minute: look at your calendar for the next four weeks and mark two days after each planned injection. If those days repeatedly fall on a big meeting, a long drive or a social event you care about, shift the injection day by one or two days until the peak lands somewhere quieter. That is the whole decision, visualised.
The pharmacokinetic detail is straightforward. Semaglutide is a GLP-1 receptor agonist with a half-life of approximately seven days. After a single injection, plasma concentration rises to its peak somewhere between day one and day three, then falls gradually until the next dose. Because the half-life is so long, a meaningful amount of the drug is still active when you inject the following week. Levels therefore accumulate dose by dose.
By around four to five weeks of weekly injections, semaglutide reaches what pharmacologists call steady state: the amount added each week roughly equals the amount cleared, so background levels stabilise at roughly two to three times higher than after a single injection. This is explored in more depth on the page covering when Wegovy peaks in your system. The practical upshot is that week one and week five feel different even at the same dose, by week five, your trough level (the lowest point just before the next injection) is substantially higher than it was at the start. That is part of why the tolerability picture often improves: the swings between peak and trough become smaller relative to the overall level.
The NHS medicines information for semaglutide confirms the once-weekly dosing schedule and the GLP-1 mechanism underpinning this gradual build-up. If you are curious about how the semaglutide peak behaves and how that timing shifts as steady state develops, that page walks through the pharmacology in detail alongside what it means for appetite signals day to day. For a closer look at when semaglutide peaks and how that timing plays out across the dosing cycle, that page covers the question in full.
Nausea is the side effect most closely tied to the post-injection peak, and it is also the one people most often misattribute to the medicine being wrong for them. It tends to be worst in the 24–72 hour window, particularly at the start of treatment or after a dose increase, because those are the moments when your body encounters the highest concentration of semaglutide it has yet experienced.
This is not unique to Wegovy. The same GLP-1 mechanism that reduces appetite also slows gastric emptying, and the stomach notices this most acutely near the peak. Common side effects, as listed in the NHS semaglutide medicines guide, include nausea, vomiting, diarrhoea, constipation and fatigue, most are most prominent in the early weeks and typically ease as the body adjusts. Eating smaller meals around the peak window, staying well hydrated and avoiding very fatty foods during those first two days can help considerably.
One thing worth knowing: if side effects feel severe or don't follow the expected pattern of improving over time, that is a conversation for your prescriber rather than something to push through alone. Aftercare exists for exactly this reason. You can also find general support through the nume FAQs.
Understanding the peak is genuinely useful before you begin, not just once you are already managing nausea on a Tuesday morning. It reframes side effects as predictable and time-limited rather than random. It explains why missing a dose by a day or two can unsettle your rhythm in ways that missing a daily tablet would not. And it clarifies why titration (the gradual step-up from 0.25mg through to the 2.4mg maintenance dose) is structured the way it is: each new dose introduces a higher peak, so the body is given time to adapt before the next increase.
If you are comparing Wegovy with tirzepatide (Mounjaro) or considering which treatment suits your situation, the weight-loss treatment overview covers the licensed options clearly. Cost is a real consideration too; the Wegovy price comparison page sets out what private treatment typically costs in the UK and what an honest price should include. For a broader look at how semaglutide works across its different uses, the semaglutide overview is a useful starting point.
Wegovy is a prescription-only medicine. A prescriber reviews your full picture before any treatment is issued, suitability is never assumed. If you would like to talk through whether it is right for you, speak to our prescribers via a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.